High-Intensity Functional Training on Physical Performance and Mental Health in Elderly With Sarcopenia
Effect of High-Intensity Functional Training on Physical Performance and Mental Health in Elderly With Sarcopenia
1 other identifier
interventional
60
1 country
1
Brief Summary
Sixty patients with age ranged from 60 to 70 years old with individuals who will be found to have sarcopenia will participate in the study, and will be recruited from nursing home in AL-Abadiyah. Patients will be assigned into two equal groups randomly: Group(A):N= 30 Patients in this group will receive high-intensity functional training exercises 3 times per week for 10 weeks. The initial duration of each session was 30 min, and it could be increased progressively, along with the intensity of the exercises, up to 50 min. All sessions included the following: i. 5 min warm-up ii. 40 min functional training exercises. iii. 5 min cool-down. Group (B): N=30 Patients in this group will receive sham exercises. Sham interventions are methodological tools used to treat participants in the study arm and the control arm in exactly the same way, except that the study group receives an active substance and the control group does not.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 3, 2026
CompletedFirst Posted
Study publicly available on registry
February 10, 2026
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
April 20, 2026
April 1, 2026
2 months
February 3, 2026
April 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Short Physical Performance Battery (SPPB) test
The SPPB assesses physical performance through balance, strength, and gait measurements and is made up of a set of three tests: standing static balance ; lower limb strength and power through getting up and sitting on a chair; and walking speed at normal pace. Strength and gait are first evaluated by the ability to perform the tasks of getting up and sitting on a chair five times and performing the walking speed test (3 to 4 meters) and, second, by the time the individual takes to complete the tasks. The SPPB total score ranges from 0 (worst performance) to 12 points (best performance) and categorically evaluates performance in the tests using three classes of scores: three classes: 0-6 points (poor performance), 7-9 points (moderate performance), and 10-12 points (good performance).
10 weeks
Secondary Outcomes (6)
Hand Dynamometer
10 weeks
Quadriceps strength test
10 weeks
Montreal Cognitive Assessment
10 weeks
The Katz Index
10 weeks
The Geriatric Depression Scale-15 (GDS-15)
10 weeks
- +1 more secondary outcomes
Study Arms (2)
high-intensity functional training exercises
EXPERIMENTALA) Awarm up: for 5 min, B) Functional training exercises: The participants will be initially instructed to complete up to one set of 8 maximum repetitions for each type of exercise with first and second week, followed by two sets of 8 maximum repetitions in the third and fourth week, Then three sets of 12 maximum repetitions from the fifth week untile the end of the study I. Sit to stand( Chair squats) II. Wall push up: III. Overhead triceps extension: IV. Leg kickbacks V. Wood chops exercise VI. Farmer's Carry training C) A cool down: for 5 min slow continuation of the activity.
sham therapy
SHAM COMPARATORGroup (B): N=30 Patients in this group who will be found to have sarcopenia will receive sham exercises. Sham interventions are methodological tools used to treat participants in the study arm and the control arm in exactly the same way, except that the study group receives an active substance and the control group does not.Sham exercises that is commonly administrated as a light touch in the body or mimics the active treatment and aims at blinding of participants
Interventions
A) Awarm up: for 5 min.warm-up (predominantly stretching) of the neck, shoulders, lower back, hips, knees and ankles. B) Functional training exercises: The participants will be initially instructed to complete up to one set of 8 maximum repetitions for each type of exercise with first and second week, followed by two sets of 8 maximum repetitions in the third and fourth week, Then three sets of 12 maximum repetitions from the fifth week untile the end of the study. I. Sit to stand( Chair squats) II. Wall push up III. Overhead triceps extension IV. Leg kickbacks V. Wood chops exercise VI. Farmer's Carry training C) A cool down: for 5 min slow continuation of the activity, allows a more gradual reduction in heart rate and increased peripheral vascular resistance, with return of blood flow from the periphery Farmer's Carry training
The participants in the control group will receive sham exercises that is commonly administrated as a light touch in the body or mimics the active treatment and aims at blinding of participants.
Eligibility Criteria
You may qualify if:
- Old individuals who will be found to have sarcopenia as defined according to European Working Group on Sarcopenia in Older People (EWGSOP2) 2019 criteria, The EWGSOP2 defines sarcopenia as a muscle disease characterized by progressive and generalized loss of skeletal muscle mass and function. Diagnosis requires sequential assessment of three components
- Low Muscle Strength: The primary criterion. Measured by:
- Handgrip strength: Cut-offs are \<27 kg for men and \<16 kg for women using a dynamometer.
- Chair Stand Test: ≥15 seconds for five rises indicates weakness.
- Low Muscle Quantity or Quality: Assessed via:
- o calf circumference (≤34 cm men, ≤33 cm women).
- Poor Physical Performance: Indicates severe sarcopenia. Tests include:
- Gait speed: ≤0.8 m/s over 4 meters.
- Short Physical Performance Battery (SPPB): ≤8 points.
- Timed Up-and-Go (TUG): ≥20 seconds.
- Age from 60 to 70 years old.
- Old individuals who will be found to have mild depression.
You may not qualify if:
- Neurological disorders.
- Vestibular or balance disorders.
- Uncontrolled hypertension or heart diseases.
- Recent surgeries or fractures.
- Any psychological disorders.
- Severe renal failure (glomerular filtration rate \< 30 mL/min).
- moderate to severe liver failure.
- The patients cannot follow instructions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Faculty of Physical Therapy
Giza, 12613, Egypt
MeSH Terms
Interventions
Study Officials
- PRINCIPAL INVESTIGATOR
Research Ethical Committee Faculty of Physical Therapy - Cairo University
Cairo University
Central Study Contacts
Research Ethical Committee Faculty of Physical Therapy - Cairo University
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physiotherapy Specialist at Damanhur Medical National Institute, EL-Behira, Egypt
Study Record Dates
First Submitted
February 3, 2026
First Posted
February 10, 2026
Study Start
May 1, 2026
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
April 20, 2026
Record last verified: 2026-04